Acta Neuropathol

1. WALDMAN AD, Catania C, Pisa M, Jenkinson M, et al
   The prevalence and topography of spinal cord demyelination in multiple sclerosis: a retrospective study.
   Acta Neuropathol. 2024;147:51.
   

   >> Share

   
   

   
   Ann Neurol

2. MARGONI M, Pagani E, Meani A, Preziosa P, et al
   Cognitive Impairment Is Related to Glymphatic System Dysfunction in Pediatric Multiple Sclerosis.
   Ann Neurol. 2024 Mar 13. doi: 10.1002/ana.26911.
   

   >> Share

   
   

   
   J Neuroimmunol

3. FOGEL A, Olcer M, Goel A, Feng X, et al
   Novel biomarkers and interferon signature in secondary progressive multiple sclerosis.
   J Neuroimmunol. 2024;389:578328.
   

   >> Share

   
   

   
   J Neurol Neurosurg Psychiatry

4. JONS D, Grut V, Bergstrom T, Zetterberg H, et al
   Seroreactivity against lytic, latent and possible cross-reactive EBV antigens appears on average 10 years before MS induced preclinical neuroaxonal damage.
   J Neurol Neurosurg Psychiatry. 2024;95:325-332.
   

   >> Share

   
   

   
   Mult Scler

5. JOHNSSON M, Stenberg YT, Farman HH, Blennow K, et al
   Serum neurofilament light for detecting disease activity in individual patients in multiple sclerosis: A 48-week prospective single-center study.
   Mult Scler. 2024 Mar 13:13524585241237388. doi: 10.1177/13524585241237388.
   

   >> Share

   
   
6. NAKAMURA K, Sun Z, Hara-Cleaver C, Bodhinathan K, et al
   Natalizumab reduces loss of gray matter and thalamic volume in patients with relapsing-remitting multiple sclerosis: A post hoc analysis from the randomized, placebo-controlled AFFIRM trial.
   Mult Scler. 2024 Mar 12:13524585241235055. doi: 10.1177/13524585241235055.
   

   >> Share

   
   
7. EHLING R, Seebacher B, Brenneis C
   Letter to the editor: Mobile health interventions in multiple sclerosis: A systematic review.
   Mult Scler. 2024 Mar 11:13524585241234789. doi: 10.1177/13524585241234789.
   

   >> Share

   
   
8. KUBICKI K, Stefoski D
   Iatrogenic myelodysplastic syndrome complicating multiple sclerosis: A case report.
   Mult Scler. 2024 Mar 8:13524585241235539. doi: 10.1177/13524585241235539.
   

   >> Share

   
   
9. VAN KEMPEN ZL, van Dam KP, Keijser JB, Stalman EW, et al
   Longitudinal increase of humoral responses after four SARS-CoV-2 vaccinations and infection in MS patients on fingolimod.
   Mult Scler. 2023 Nov 9:13524585231207761. doi: 10.1177/13524585231207761.
   

   >> Share

   
   

   
   Neurologia (Engl Ed)

10. JIMENEZ-MORALES RM, Broche-Perez Y, Macias-Delgado Y, Sebrango C, et al
    Cognitive rehabilitation program in patients with multiple sclerosis: A pilot study.
    Neurologia (Engl Ed). 2024;39:135-146.
    

    >> Share

    
    
11. TREJO-GABRIEL-GALAN JM
    Euthanasia and assisted suicide in neurological diseases: a systematic review.
    Neurologia (Engl Ed). 2024;39:170-177.
    

    >> Share

    
    

    
    Rev Neurol

12. BARBOZA A, Sinay V, Alonso R, Carnero-Contentti E, et al
    [Comorbidities in multiple sclerosis and their influence on the choice of treatment].
    Rev Neurol. 2024;78:157-170.
    

    >> Share

    
    

    
    Rev Neurol (Paris)

13. MRABET S, Falfoul Y, Bouassida M, Souissi A, et al
    Retinal changes in multiple sclerosis: An optical coherence tomography and angiography study.
    Rev Neurol (Paris). 2024 Mar 7:S0035-3787(24)00421.
    

    >> Share

    
    

Free Medical Abstracts
Privacy Policy
Sponsors
Share